These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23647200)

  • 1. Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.
    Roche D; Gil D; Giraldo J
    Br J Pharmacol; 2013 Jul; 169(6):1189-202. PubMed ID: 23647200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The operational model of allosteric modulation of pharmacological agonism.
    Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V
    Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of receptor allosterism and its implication for drug discovery.
    Zhang R; Kavana M
    Expert Opin Drug Discov; 2015 Jul; 10(7):763-80. PubMed ID: 25927503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites.
    Gregory KJ; Giraldo J; Diao J; Christopoulos A; Leach K
    Mol Pharmacol; 2020 Jan; 97(1):35-45. PubMed ID: 31704718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.
    Leach K; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2007 Aug; 28(8):382-9. PubMed ID: 17629965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.
    Ehlert FJ; Griffin MT
    J Pharmacol Toxicol Methods; 2014; 69(3):253-79. PubMed ID: 24434717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D; Miller LJ
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the allosteric interactions within a G-protein-coupled receptor heterodimer.
    Zhou B; Giraldo J
    Drug Discov Today; 2018 Jan; 23(1):7-11. PubMed ID: 28756203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein coupled receptors as allosteric proteins and the role of allosteric modulators.
    Kenakin T
    J Recept Signal Transduct Res; 2010 Oct; 30(5):313-21. PubMed ID: 20858023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.
    Christopoulos A; Changeux JP; Catterall WA; Fabbro D; Burris TP; Cidlowski JA; Olsen RW; Peters JA; Neubig RR; Pin JP; Sexton PM; Kenakin TP; Ehlert FJ; Spedding M; Langmead CJ
    Pharmacol Rev; 2014 Oct; 66(4):918-47. PubMed ID: 25026896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric drugs and seven transmembrane receptors.
    Kenakin T
    Curr Top Med Chem; 2013; 13(1):5-13. PubMed ID: 23409762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Modulation of Alpha7 Nicotinic Receptors: Mechanistic Insight through Metadynamics and Essential Dynamics.
    Grazioso G; Sgrignani J; Capelli R; Matera C; Dallanoce C; De Amici M; Cavalli A
    J Chem Inf Model; 2015 Dec; 55(12):2528-39. PubMed ID: 26569022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands.
    Hudson BD; Christiansen E; Murdoch H; Jenkins L; Hansen AH; Madsen O; Ulven T; Milligan G
    Mol Pharmacol; 2014 Aug; 86(2):200-10. PubMed ID: 24870406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Biased Agonism.
    Ehlert FJ
    Prog Mol Biol Transl Sci; 2018; 160():63-104. PubMed ID: 30470293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.